Search

Your search keyword '"Tina Parkner"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Tina Parkner" Remove constraint Author: "Tina Parkner"
38 results on '"Tina Parkner"'

Search Results

1. Serum GFAP – reference interval and preanalytical properties in Danish adults

2. Serum GFAP - pediatric reference interval in a cohort of Danish children

3. Reference intervals for plasma vitamin B12 and plasma/serum methylmalonic acid in Danish children, adults and elderly

4. Diagnostic Cut-offs for CSF β-amyloid and tau proteins in a Danish dementia clinic

5. Short-term biological variation of serum glial fibrillary acidic protein

6. Plasma calprotectin - preanalytical stability and interference from hemolysis

7. Vitamin B12 deficiency: correction of P-methylmalonic acid for estimated glomerular filtration rate to improve diagnostic value - a confirmatory study

8. Biotin interference in routine IDS-iSYS immunoassays for aldosterone, renin, insulin-like growth factor 1, growth hormone and bone alkaline phosphatase

9. Reference interval and preanalytical properties of serum neurofilament light chain in Scandinavian adults

10. Procollagen III, N-terminal propeptide (PIIINP): Establishment of reference intervals in Northern European adults and children using the MAGLUMI 800 chemiluminescence immunoassay

11. Anti-transglutaminase IgA antibody measurement in coeliac disease: Method comparison IDS-iSYS vs. Thermo Fisher Phadia

12. Plasma neurofilament light chain is associated with mortality after spontaneous intracerebral hemorrhage

13. Plasma Neurofilament Light Chain Is Associated with Poor Functional Outcome and Mortality Rate After Spontaneous Subarachnoid Hemorrhage

14. Diagnostic Accuracy of a Point-of-Care Test for Celiac Disease Antibody Screening among Infertile Patients

15. Reference limits for GAD65 and IA-2 autoantibodies by chemiluminescence immunoassay in Northern European adults and children

16. Home Management of Warfarin Treatment Through a Real-Time Supervised Telemedicine Solution:A Randomized Controlled Trial

17. Unrecognised coeliac disease among men and women undergoing fertility treatment:A screening study

18. A Comparison of ree Chromogranin A Assays in Patients with Neuroendocrine Tumours

19. Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patients

20. Soluble CD163: a biomarker linking macrophages and insulin resistance

21. Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetes1

22. Interaction between exogenous insulin, endogenous insulin, and glucose in type 2 diabetes patients

23. Visceral obesity is associated with increased soluble CD163 concentration in men with type 2 diabetes mellitus

24. Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes

25. Impact of moderate interval exercise versus supine rest on the pharmacokinetics and pharmacodynamic profiles of subcutaneously administered growth hormone in adult growth hormone deficient patients

27. A comparison of three chromogranin A assays in patients with neuroendocrine tumours

29. A comparison of pharmacokinetics and pharmacodynamics of insulin aspart, biphasic insulin aspart 70, biphasic insulin aspart 50, and human insulin: a randomized, quadruple crossover study

30. IDegAsp:a novel soluble insulin analogs combination

31. Do all patients with type 2 diabetes need breakfast?

32. Obesity does not influence the unique pharmacological properties of different biphasic insulin aspart preparations in patients with type 2 diabetes

33. Overnight versus 24 hours of continuous subcutaneous insulin infusion as supplement to oral antidiabetic drugs in type 2 diabetes

34. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes

35. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

36. P02-46 Diurnal variation in the pharmacokinetics of growth hormone administered as a continuous subcutaneous infusion in GH-deficient subjects

38. Pharmacokinetics following continuous subcutaneous insulin infusion of insulin aspart with or without initial subcutaneous bolus

Catalog

Books, media, physical & digital resources